Catalyst Capital Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
+1,360
| New | +$106K | ﹤0.01% | 324 |
|
|
2025
Q1 | – | Sell |
-726
| Closed | -$53.7K | – | 471 |
|
|
2024
Q4 | $53.7K | Buy |
+726
| New | +$53.7K | ﹤0.01% | 375 |
|
|
2018
Q4 | – | Sell |
-1,725
| Closed | -$100K | – | 433 |
|
|
2018
Q3 | $100K | Sell |
1,725
-300
| -15% | -$17.4K | ﹤0.01% | 255 |
|
|
2018
Q2 | $98K | Sell |
2,025
-58,425
| -97% | -$2.83M | ﹤0.01% | 261 |
|
|
2018
Q1 | $2.81M | Sell |
60,450
-20,700
| -26% | -$963K | 0.1% | 106 |
|
|
2017
Q4 | $3.05M | Buy |
81,150
+6,150
| +8% | +$231K | 0.11% | 101 |
|
|
2017
Q3 | $2.73M | Buy |
75,000
+44,400
| +145% | +$1.62M | 0.12% | 110 |
|
|
2017
Q2 | $1.21M | Buy |
+30,600
| New | +$1.21M | 0.05% | 163 |
|
|
2016
Q3 | – | Sell |
-30,000
| Closed | -$997K | – | 420 |
|
|
2016
Q2 | $997K | Buy |
+30,000
| New | +$997K | 0.18% | 135 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 436 |
|
|
2015
Q4 | – | Sell |
-8,478
| Closed | -$201K | – | 438 |
|
|
2015
Q3 | $201K | Sell |
8,478
-2,394
| -22% | -$56.8K | 0.03% | 240 |
|
|
2015
Q2 | $258K | Sell |
10,872
-12
| -0.1% | -$285 | 0.03% | 284 |
|
|
2015
Q1 | $258K | Sell |
10,884
-3,966
| -27% | -$94K | 0.03% | 264 |
|
|
2014
Q4 | $315K | Buy |
14,850
+3,438
| +30% | +$72.9K | 0.04% | 275 |
|
|
2014
Q3 | $194K | Buy |
+11,412
| New | +$194K | 0.03% | 296 |
|
|
2013
Q4 | – | Sell |
-102,540
| Closed | -$1.19M | – | 268 |
|
|
2013
Q3 | $1.19M | Buy |
102,540
+54,588
| +114% | +$634K | 0.65% | 42 |
|
|
2013
Q2 | $537K | Buy |
+47,952
| New | +$537K | 0.42% | 92 |
|